Sou Hu Cai Jing·2025-10-06 00:37Core Viewpoint - The trend of A-share companies planning to list in Hong Kong continues, with a significant number of firms seeking to expand their financing channels and enhance their international presence [1][4][8]. Group 1: A-Share Companies Planning to List in Hong Kong - As of September 30, three A-share companies, XinNuoWei, Kexing Pharmaceutical, and KOTAI Power, announced plans to list in Hong Kong, bringing the total to 25 companies that have made such announcements in September alone [1][3]. - A total of 76 A-share companies have submitted listing applications to the Hong Kong Stock Exchange and are awaiting hearings as of October 2 [1][6]. Group 2: Industry Distribution and Notable Companies - The companies planning to list cover various industries, including pharmaceuticals, technology, and consumer goods, indicating a broad interest across sectors [6]. - Notable companies among those planning to list include Kexing Pharmaceutical, which aims to enhance its international strategy and financing capabilities, and XinNuoWei, which focuses on global expansion and capital operations [4][5]. Group 3: Financing and Market Trends - The "A+H" listing model has seen significant fundraising success, with 11 A-share companies raising a total of 916.89 billion HKD this year, accounting for over 50% of the total IPO financing in Hong Kong [8]. - The Hong Kong Stock Exchange has experienced a surge in new stock issuance, with total financing reaching 1,345 billion HKD by the end of August, marking a nearly sixfold increase compared to the same period in 2024 [8].